ALK L1196M
|
NSCLC
|
ALK L1196M
|
NSCLC
|
alectinib Sensitive: C3 – Early Trials
|
alectinib Sensitive: C3 – Early Trials
|
ALK L1196M
|
NSCLC
|
ALK L1196M
|
NSCLC
|
crizotinib Resistant: C3 – Early Trials
|
crizotinib Resistant: C3 – Early Trials
|
ALK L1196M
|
NSCLC
|
ALK L1196M
|
NSCLC
|
ceritinib Sensitive: C3 – Early Trials
|
ceritinib Sensitive: C3 – Early Trials
|